新诊断老年多发性骨髓瘤患者的综合老年评估:多中心前瞻性非干预研究
该多中心前瞻性非干预研究纳入349例65-86岁新诊断多发性骨髓瘤患者,评估综合老年评估(CGA)在真实世界中的可行性及基线特征。采用IMWG-GA标准,本队列衰弱患者比例显著高于IMWG队列(43% vs 30%,P=0.002),且IMWG-GA「fit」组中仍存在营养不良、抑郁和认知障碍风险。中位随访26个月,中位总生存期34.7个月,估计3年OS率50%。
要点
- CGA在老年新诊断MM患者中可行,本队列衰弱比例显著高于IMWG队列。
- IMWG-GA评定为「fit」的患者仍存在营养不良、抑郁和认知障碍风险。
- 高MNA-SF评分、低GDS评分和高CCI评分可用于预测老年新诊断MM患者OS。
核心结论
- 研究支持在新诊断老年多发性骨髓瘤患者中开展综合老年评估。
研究设计与样本
- 多中心、前瞻性、非干预性研究,纳入349例65-86岁新诊断多发性骨髓瘤老年患者。
主要发现
- 本队列衰弱患者比例显著高于IMWG队列(43% vs 30%,P=0.002)。
- IMWG-GA「fit」组中仍存在营养不良、抑郁和认知障碍风险。
- 中位随访26个月(范围1-38),中位总生存期34.7个月,估计3年OS率50%。
- 高MNA-SF评分(MNA-SF ≥ 12)、低GDS评分(GDS ≤ 5)和高CCI评分(CCI ≥ 2)可预测老年新诊断MM患者OS。
关键数值与推荐
- IMWG-GA基于年龄、功能状态和合并症区分fit与frail患者。
- MNA-SF ≥ 12、GDS ≤ 5、CCI ≥ 2可用于预测OS。
临床怎么用
- 对老年新诊断MM患者应开展CGA以识别衰弱及营养不良、抑郁、认知障碍等可干预问题。
- 即使IMWG-GA评为fit,仍需关注营养不良、抑郁和认知障碍风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple myeloma is a disease of the older people, whose prognoses are highly heterogeneous. The International Myeloma Working Group (IMWG) proposed a geriatric assessment (GA) based on age, functional status and comorbidities to discriminate between fit and frail patients. Given the multidimensional nature of frailty and the relatively recent exploration of frailty in the field of MM, reaching a consensus on the measurement of frailty in MM patients remains challenging. OBJECTIVE: We sought to assess the feasibility of performing a comprehensive GA (CGA) in older MM patients in a real-world and multicentre setting and to evaluate their baseline CGA profiles. RESULTS: We studied 349 older patients with newly diagnosed MM (age range, 65-86 years). Our results showed that a CGA is feasible for older MM patients. Using the IMWG-GA criteria, we identified significantly more frail patients in our cohort comparing to in the IMWG cohort (43% vs 30%, P = 0.002). In the IMWG-GA 'fit' group, risk of malnutrition, depression and cognitive impairment remains. The median follow-up time was 26 months (range 1-38). The median overall survival (OS) was 34.7 months, and the estimated 3-year OS rate was 50%. A high MNA-SF score (MNA-SF ≥ 12), low GDS score (GDS ≤ 5) and high CCI score (CCI ≥ 2) can be used to predict the OS of older patients with newly diagnosed MM. This study is registered at www.clinicaltrials.gov (NCT03122327). CONCLUSIONS: Our study justifies the need for a CGA in older patients with newly diagnosed MM.
引用
- Yao Y, Sui WW, Liao AJ, et al. Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study. Age Ageing. 2022. PMID: 34673897. doi:10.1093/ageing/afab211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。